Terri Leahy

Phase 0 Trials: An Industry Perspective

H. Eliopoulos, V. Giranda, R. Carr, 2008, Clinical Cancer Research.

Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer.

Terri Leahy, G. Groenewegen, E. Voest, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Atrasentan : An Endothelin Receptor Antagonist for Refractory Prostate Cancer 1

Terri Leahy, G. Groenewegen, E. Voest, 2003 .